Viewing StudyNCT05262400

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 5:19 PM
Last Modification Date: 2024-10-26 @ 2:26 PM
Study NCT ID: NCT05262400
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-04
First Post: 2022-02-21
Brief Title: A Study to Learn About the Study Medicine Called PF-07220060 in Combination With PF-07104091 In Participants With Breast Cancer and Solid Tumors
Sponsor: Pfizer
Organization: Pfizer
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Solid Tumors
Breast Cancer
Keywords:
Name View
cyclin-dependent kinase 2 CDK2 View
cyclin-dependent kinase 4 CDK4 View
estrogen receptor-positivehuman epidermal growth factor receptor 2 negative ERHER2- View
estrogen receptor-positiverefractory hormone receptor positive ERHER2 View
hormone receptor positivehuman epidermal growth factor receptor 2 negative HRHER2- View